Cargando…

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness

Detalles Bibliográficos
Autores principales:	Liu, Wenyi, Wu, Min, Shen, Guanwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969033/ https://www.ncbi.nlm.nih.gov/pubmed/36849547 http://dx.doi.org/10.1038/s41392-023-01349-z

Ejemplares similares

Base editing: a promising tool to rescue spinal muscular atrophy
por: Bhatia, Priyanka, et al.
Publicado: (2023)

On demand CRISPR-mediated RNA N6-methyladenosine editing
por: Xu, Ying, et al.
Publicado: (2022)

CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites
por: Lee, Marcus CS, et al.
Publicado: (2014)

Editing base in mouse model
por: Wang, Haoyi
Publicado: (2017)

CRISPR-mediated gene editing to rescue haploinsufficient obesity syndrome
por: Wang, Zhifeng, et al.
Publicado: (2019)

High-throughput base editing: a promising technology for precision medicine and drug discovery
por: Sachinidis, Agapios
Publicado: (2021)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing
por: Meng, Ning, et al.
Publicado: (2021)

Adenine base editing to mimic or correct disease mutations in rodents
por: Ren, Ruotong, et al.
Publicado: (2018)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
por: Xu, MengMeng
Publicado: (2020)

CRISPR base editor treats premature-aging syndrome
por: Lin, Ping, et al.
Publicado: (2021)

Promoting RNA editing by ADAR attraction
por: Danan-Gotthold, Miri, et al.
Publicado: (2017)

Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses
por: Lin, Ping, et al.
Publicado: (2022)

Rescuing the Golgi from heat damages by ATG8: restoration rather than clean-up
por: Luo, Anni, et al.
Publicado: (2023)

Understanding and repurposing CRISPR-mediated alternative splicing
por: Smith, Jordan L., et al.
Publicado: (2018)

Genome editing enables defense-yield balance in rice
por: Deng, Yiwen, et al.
Publicado: (2023)

Eva to the rescue
por: Chirigati, Fernando
Publicado: (2021)

mRNA vaccine shows promise in autoimmunity
por: Flemming, Alexandra
Publicado: (2021)

Deletion of the RNA-editing enzyme ADAR1A: new strategy to potentiate responses to PD-1 immune checkpoint blockade
por: Wang, Manni, et al.
Publicado: (2019)

Skeletal Editing—Nitrogen Deletion of Secondary Amines by Anomeric Amide Reagents
por: Zippel, Christoph, et al.
Publicado: (2021)

A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues
por: Min, Long, et al.
Publicado: (2022)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Prime time for base editing in the mitochondria
por: Morgan, Michael A., et al.
Publicado: (2022)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

New insights into pathogen-mediated modulation of host RNA splicing
por: Gao, Chuyun, et al.
Publicado: (2022)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Identification of evolutionarily meaningful information within the mammalian RNA editing landscape
por: Savva, Yiannis A, et al.
Publicado: (2014)

Dietary reprogram of macrophages for cell competition: a promising strategy for malignant cancer control
por: Chen, Jian, et al.
Publicado: (2023)

Pop in, pop out: a novel gene-targeting strategy for use with CRISPR-Cas9
por: Kühn, Ralf, et al.
Publicado: (2015)

CRISPR sabotage
por: van der Oost, John, et al.
Publicado: (2015)

Pandemic Woes: Antigen Tests to the Rescue?
por: Weiss, Peter
Publicado: (2021)

Decoding γδ T cell anticancer therapies: integrating CRISPR screens with tumor organoids
por: Zhou, Jian, et al.
Publicado: (2023)

Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Base editing: a novel cure for severe combined immunodeficiency
por: Ha, Teng-Cheong, et al.
Publicado: (2023)

Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy
por: Peng, Xuerun, et al.
Publicado: (2021)

Advantages of using the CRISPR/Cas9 system of genome editing to investigate male reproductive mechanisms using mouse models
por: Young, Samantha AM, et al.
Publicado: (2015)

FcγRIIb blockage: a promising immunotherapy target for severe COVID-19
por: He, Xuemei, et al.
Publicado: (2021)

Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ot42nol6c7tnagjrogf9op4h2s